Endobronchial Ultrasound Biopsy Market Is Expanding Owing To Increasing Cases Of Respiratory Disorders And Growing Geriatric Population 2028 | Boston Scientific Corporation, Medtronic PLC, Olympus Corporation, Cook Medical Incorporated

Endobronchial Ultrasound Biopsy Market Is Expanding Owing To Increasing Cases Of Respiratory Disorders And Growing Geriatric Population

Overview:

An endobronchial ultrasound can help doctors determine whether or not a patient has lung cancer. It helps physicians obtain tissue and mediastinal lymph nodes. In contrast to a biopsy, an EBUS allows healthcare providers to see inside the lungs allowing doctors to determine the stage of the cancer. The growth of the endobronchial ultrasound biopsy market is due to the fact that it is a minimally invasive procedure, which is becoming more popular across the world. As compared to open surgeries, endobronchial ultrasound biopsy involves only a few small incisions. Moreover, there is less tissue damage and discomfort, which helps in reducing the risk of surgical scarring.

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4146

Market Dynamics:

Factors such as large number of patients with respiratory diseases and growing demand for less invasive procedures are expected to boost growth of the global endobronchial ultrasound biopsy market during the forecast period. Endobronchial ultrasound procedures are used for diagnosing various types of lung disorders and growing cases of respiratory diseases are driving the demand for endobronchial ultrasound biopsy. For instance, the Health and Safety Executive (HSE), UK published Occupation Lung Disease statistics in Great Britain in December 2021, according to which, 17,000 estimated new self-reported breathing or lung problems cases were registered in 2021 in the U.K.

However, complications associated with sedation like hypotension and hypoxemia that can possibly occur during the procedures, are likely to hinder growth of the global endobronchial ultrasound biopsy market over the forecast period.

Impact of COVID-19:

The COVID-19 pandemic adversely affected various industries. The outbreak of COVID-19 virus led to countries shutting down borders and implementing strict lockdown regulations. Due to this, non-emergency hospital procedures were suspended, which further affected growth of the endobronchial ultrasound biopsy market. However, increasing cases of COVID-19 boosted the demand for endobronchial ultrasound biopsy as patients with lung diseases were at high risk if they contracted COVID-19.

𝐓𝐨 𝐆𝐞𝐭 a Free 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/4146

Key Takeaways:

• The global endobronchial ultrasound biopsy market is expected to grow with a CAGR of 5.1% during the forecast period, owing to rising geriatric population and cases of diseases requiring endoscopic ultrasound operations. For instance, as per the World Bank data, in 2020 the total old age population aging 65 and above was 9.321% of the entire global population, which is 723,184,486.
• North America is anticipated to witness significant growth in the global endobronchial ultrasound biopsy market over the forecast period, owing to high prevalence of lung diseases such as lung cancer, and presence of well-structured healthcare system promoting research and technological developments in the region.
• Major players functioning in the global endobronchial ultrasound biopsy market are Simbionix USA Corporation, Boston Scientific Corporation, FUJIFILM Corporation, Veran Medical Technologies, Medtronic PLC, Cook Medical Incorporated, Pentax Medical, Olympus Corporation, and Medi-Globe Corporation.